# European Trial of Immunosuppression in SPK Tx

> **NCT00140543** · PHASE3 · COMPLETED · sponsor: **EUROSPK Study Group** · enrollment: 228 (—)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetic Nephropathy

## Interventions

- **DRUG:** sirolimus versus mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00140543
- **Lead sponsor:** EUROSPK Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2005-09-30
- **Target enrollment:** 228 (—)
- **Last updated:** 2021-08-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140543, "European Trial of Immunosuppression in SPK Tx". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00140543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*